PanGen Biotech

PanGen Biotech EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of PanGen Biotech (222110.KQ) as of Oct 19, 2026 is 375.37. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 20.03 — a change of 1,774.28% (higher).

EV/OCF

375.37

YoY

1,774.28%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of PanGen Biotech is 2025 375.37 . EV/OCF (Enterprise Value to Operating Cash Flow) of PanGen Biotech was 2024 20.03 . It decreases by 1,774.28% higher compared to the previous year.

The PanGen Biotech EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
-7.54 KRW
Jan 1, 2019
-12.80 KRW
Jan 1, 2020
-11.24 KRW
Jan 1, 2021
-14.25 KRW
Jan 1, 2022
-20.34 KRW
Jan 1, 2023
-20.64 KRW
Jan 1, 2024
20.03 KRW
Jan 1, 2025
375.37 KRW
The PanGen Biotech EV/OCF history
YEAREV/OCFYoY
375.37+1,774.28%
20.03-197.05%
-20.64+1.44%
-20.34+42.79%
-14.25+26.75%
-11.24-12.21%
-12.80+69.72%
-7.54-90.72%
-81.28+570.41%
-12.12-74.16%
-46.92-16.30%
-56.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PanGen Biotech Stock analysis

What does PanGen Biotech do? PanGen Biotech Inc is a biotechnology company based in Suwon, South Korea, with 73 employees. It went public on March 11, 2016. The company develops biopharmaceutical products and provides contract manufacturing services for biopharmaceuticals, including technology transfer for Chinese hamster ovary (CHO) cell line production. It also offers reagents for biopharmaceutical development and develops biosimilar products such as Biosimilar EPO, Recombinant Factor VIII, and Biosimilar G-CSF. Services are provided domestically and to international markets including China, India, Mexico, the United States, and Europe. PanGen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PanGen Biotech stock

EV/OCF (Enterprise Value to Operating Cash Flow) of PanGen Biotech is 375.37 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of PanGen Biotech changed from 20.03 to 375.37, representing a 1,774.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) PanGen Biotech since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s PanGen Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — PanGen Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — PanGen Biotech